期刊文献+

血清HbA1c、Alarin及Ficolin-3水平对妊娠期糖尿病患者妊娠结局的预测价值 被引量:10

Clinical value of serum HbA1c,Alarin and Ficolin-3 levels in predicting pregnancy outcome in patients with gestational diabetes mellitus
暂未订购
导出
摘要 目的探讨妊娠期糖尿病(GDM)患者血清糖化血红蛋白A1c(HbA1c)、Alarin及纤维凝胶蛋白-3(Ficolin-3)联合对不良妊娠结局的预测价值。方法选取入院产检并住院分娩的129例GDM患者为GDM组,选取同期于本院产检并分娩的133例糖耐量试验结果正常孕妇作为对照组。采用全自动糖化血红蛋白分析仪检测血清HbA1c水平;酶联免疫吸附试验检测血清Alarin和Ficolin-3水平;Pearson法分析GDM患者血清HbA1c、Alarin、Ficolin-3水平与餐后2 h血糖(2 h PG)、空腹血糖(FBG)、胰岛素抵抗指数(HOMA-IR)的相关性;Logistic回归分析HbA1c、Alarin、Ficolin-3水平与GDM患者发生不良妊娠结局的关系;绘制受试者工作特征(ROC)曲线,分析血清HbA1c、Alarin、Ficolin-3水平对GDM患者发生不良妊娠结局的预测价值。结果GDM组2 h PG、FBG、HOMA-IR及血清HbA1c、Alarin、Ficolin-3水平均高于对照组(P<0.05)。GDM患者血清HbA1c、Alarin、Ficolin-3水平与2 h PG、FBG、HOMAIR均呈正相关(P<0.05)。血糖控制差的GDM患者血清HbA1c、Alarin、Ficolin-3水平均高于血糖控制好的GDM患者(P<0.05)。不良妊娠结局的GDM患者上述三指标水平均高于无不良妊娠结局GDM患者(P<0.05)。HbA1c、Alarin、Ficolin-3水平升高均是GDM患者发生不良妊娠结局的独立危险因素(P<0.05)。HbA1c、Alarin、Ficolin-3单独及联合预测GDM患者发生不良妊娠结局的曲线下面积分别为0.840、0.865、0.815和0.979。结论GDM患者血清HbA1c、Alarin、Ficolin-3水平异常升高,三者联合检测可提高不良妊娠结局的预测价值。 Objective To explore the value of the combination of serum hemoglobin A1c(HbA1c),Alarin and Ficolin-3 in predicting adverse pregnancy outcomes in patients with gestational diabetes mellitus(GDM).Methods From March 2021 to March 2023,129 GDM patients who underwent prenatal examination and hospital delivery in Yantai Yeda Hospital were collected as the GDM group,while 133 pregnant women with normal glucose tolerance test results were regarded as the control group.Fully automated glycated hemoglobin analyzer was applied to detect serum HbA1c level.Enzyme linked immunosorbent assay(ELISA)was applied to detect serum Alarin and Ficolin-3 levels.Pearson method was used to analyze the correlation between serum HbA1c,Alarin,Ficolin-3 levels and 2 hour postprandial glucose(2 h PG),fasting blood glucose(FBG)and homeostasis model assessment method for insulin resistance(HOMA-IR)in GDM patients.Logistic regression was applied to analyze the relationship between HbA1c,Alarin,Ficolin-3 levels and adverse pregnancy outcomes in GDM patients.Receiver operating characteristic(ROC)curve was plotted to analyze the value of serum HbA1c,Alarin and Ficolin-3 levels in predicting adverse pregnancy outcomes in GDM patients.Results The 2 h PG,FBG,HOMA-IR,and serum HbA1c,Alarin,and Ficolin-3 levels were significantly higher in the GDM group than those in the control group(P<0.05).The serum levels of HbA1c,Alarin and Ficolin-3 were positively correlated with 2 h PG,FBG and HOMA-IR in GDM patients(P<0.05).The serum HbA1c,Alarin and Ficolin-3 levels were greatly higher in GDM patients with poor blood glucose control than those in GDM patients with good blood glucose control(P<0.05).The above levels of three indicators in GDM patients with adverse pregnancy outcomes were significantly higher than those in GDM patients without adverse pregnancy outcomes(P<0.05).Elevated levels of HbA1c,Alarin and Ficolin-3 were independent risk factors for adverse pregnancy outcomes in GDM patients(P<0.05).The area under the curves of HbA1c,Alarin and Ficolin-3 alone and in combination were 0.840,0.865,0.815 and 0.979,respectively in predicting adverse pregnancy outcomes in GDM patients.Conclusion The serum HbA1c,Alarin and Ficolin-3 levels are abnormally elevated in GDM patients,and the combined detection of the three can improve the value in predicting adverse pregnancy outcomes.
作者 常鸿 张科伟 徐静 崔晓敏 杨菲菲 CHANG Hong;ZHANG Kewei;XU Jing;CUI Xiaomin;YANG Feifei(Department of Obstetrics,Yantai Yeda Hospital,Yantai 264006,China;Department of Obstetrics,the First Hospital of Hebei Medical University)
出处 《天津医药》 CAS 2024年第6期625-629,共5页 Tianjin Medical Journal
基金 河北省卫生和计划生育委员会科研基金项目(20200123)。
关键词 糖尿病 妊娠 糖基化血红蛋白A 妊娠结局 Alarin 纤维凝胶蛋白-3 diabetes,gestational glycated hemoglobin A pregnancy outcome Alarin Ficolin-3
  • 相关文献

参考文献6

二级参考文献84

  • 1Kahn CR.Joslin糖尿病学[M].14版.潘长玉,主译.北京:人民卫生出版社,2005:550-552.
  • 2中华医学会妇产科学分会产科学组,中华医学会围产医学分会妊娠合并糖尿病协作组.妊娠合并糖尿病临床诊断与治疗推荐指南(草案)[J].中华妇产科杂志,2007,42:426-428.
  • 3中华人民共和国国家卫生部.WS331-2011妊娠期糖尿病诊断[s]北京:中华人民共和国国家卫生部,2011.
  • 4International Association of Diabetes and Pregnancy 3tudy Groups Consensus Panel,Metzger BE,Gabbe SG, et al. International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy[J].Diabetes Care,2010,33:676-682.
  • 5International Diabetes Federation. Global Guideline on Pregnancy and Diabetes[S].Brussels: International Diabetes Federation,2009.
  • 6Walker JD. Diabetes in pregnancy:management of diabetes and its complications from pre-conception to the postnatal period. NICE guideline 63. London, March 2008[J]. Diabet Med, 2008, 25: 1025-1027.
  • 7Hoffman L,Nolan C,Wilson JD,et al.Gestational diabetes mellitus-management guidellnes.The Australasian Diabetes in Pregnancy Society[J].Med J Aust, 1998,169:93-97.
  • 8Canadian Diabetes Association.2008 CDA clinical practiceguidelines for the prevention and management of diabetes in Canada[J].Can J Diabetes,2008,32:S168-180.
  • 9Hadar E,Oats J,Hod M.Towards new diagnostic criteria for diagnosing GDM:the HAPO study[J].J Perinat Med, 2009, 37: 447-449.
  • 10Crowther CA,Hiller JE,Moss JR,et al.Effeet of treatment of gestational diabetes mellitus on pregnancy outeomes[J].N Engl J Med,2005,352:2477-2486.

共引文献1843

同被引文献100

引证文献10

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部